{"id":64791,"name":"CHATTEM, INC D/B/A OPELLA","slug":"chattem-inc-dba-opella","state":"NJ","country":"United States of America","description":"Healthcare related to nonprescription drugs and dietary supplements.","totalSpending":730000,"filings":5,"yearlySpending":[{"year":2025,"income":730000}],"issues":["HCR","TAX","TRD","CSP"],"firms":["CHATTEM, INC D/B/A OPELLA"],"lobbyists":["MARYANNE DUNLAP"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["Healthcare policy for non-prescription drugs and dietary supplements, tax and trade.","Healthcare policy for non-prescription drugs and dietary supplements, tax and trade.","Healthcare policy for non-prescription drugs and dietary supplements, tax and trade.","Non-prescription drug issues. Monograph reauthorization. Rx to OTC switch. HSA/FSA.","Regulatory pathways for OTC drugs and dietary supplements, including OMUFA and Rx to OTC switch."],"years":[2025]}